PDGFRα governs multiple cellular signals and plays a protective role in tumor progression

Masao Hayashi1, Noriko Okuno2, Le Thi Thu Trang2

  • 1Department of Pathology, Academic Assembly Faculty of Medicine, University of Toyama, Toyama 930-0194, Japan; Department of Dermatology, Academic Assembly Faculty of Medicine, University of Toyama, Toyama 930-0194, Japan.

Neoplasia (New York, N.Y.)
|November 4, 2025
PubMed

Insights

Platelet-derived growth factor receptor alpha (PDGFRα) in tumor cells unexpectedly promotes tumor growth and metastasis. Inhibiting PDGFRα in tumor cells may offer a targeted cancer therapy approach.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Tumor development involves complex molecular mechanisms, with many aspects still unclear.
  • Platelet-derived growth factor (PDGF) and its receptor (PDGFR) signaling pathways are implicated in cancer progression.

Purpose of the Study:

  • To investigate the role of PDGFRα in tumor progression and metastasis.
  • To elucidate the signaling pathways regulated by PDGFRα in the tumor microenvironment.

Main Methods:

  • Utilized adult PDGFRα conditional knockout (α-KO) mice implanted with Lewis lung carcinoma (LLC) cells.
  • Analyzed tumor growth, lung metastasis, vascularization, and key signaling molecules (PDGF, TGF-α, TGF-β, EGFR, AKT1).

Main Results:

  • α-KO mice showed significantly larger tumors and increased lung metastasis compared to controls.
  • PDGF-BB-PDGFRα signaling in LLC cells, activated by TGF-α, accelerated tumor growth via EGFR.
  • Hypoxia due to poor vascularization in α-KO mice led to increased TGF-β, promoting lung metastasis via AKT1.

Conclusions:

  • PDGFRα in interstitial cells plays a protective role against tumor progression.
  • Selective inhibition of PDGFRα in tumor cells could be a potential targeted cancer therapy.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.0K